Glasser's Disease

Glasser's disease is a serious systemic bacterial infection of swine caused by Glaesserella parasuis, formerly classified as Haemophilus parasuis, that produces severe inflammation of serous membranes throughout the body resulting in fibrinous polyserositis, arthritis, and meningitis. This condition primarily affects young pigs between four and eight weeks of age, particularly those experiencing the stress of weaning, transportation, or mixing with unfamiliar animals, though pigs of any age may develop disease when immunologically naive animals encounter virulent bacterial strains. The disease was first described by German veterinarian Karl Glässer in 1910 and has since been recognized as one of the most economically significant bacterial diseases affecting modern swine production systems worldwide.

Glaesserella parasuis is a normal inhabitant of the upper respiratory tract in healthy swine, with most pigs becoming colonized shortly after birth through contact with their dams and littermates during the nursing period. At least fifteen distinct serovars of the organism have been identified, with serovars 4, 5, 12, 13, and 14 most commonly associated with clinical disease, while other serovars appear to have limited pathogenic potential and colonize pigs without causing illness. The transition from harmless commensal organism to invasive pathogen depends on complex interactions between bacterial virulence factors, host immune status, environmental stressors, and co-infections with other respiratory pathogens that may compromise mucosal barrier function.

The economic impact of Glasser's disease extends beyond direct mortality losses to encompass treatment costs, reduced growth performance in recovered animals, increased labor for disease management, and potential long-term effects on herd productivity when the disease becomes endemic. High-health and specific-pathogen-free herds often experience the most severe outbreaks because pigs in these systems lack maternal antibody protection and prior exposure that would provide immunity against virulent strains, making introduction of disease into naive populations particularly devastating. Conversely, herds with endemic Glaesserella parasuis circulation typically experience sporadic individual cases rather than explosive outbreaks, as maternal immunity and early exposure provide partial protection to young pigs during the vulnerable post-weaning period.

Successful management of Glasser's disease requires an integrated approach combining early detection and treatment of clinical cases, strategic vaccination programs, attention to environmental and management factors that influence disease expression, and careful biosecurity practices that prevent introduction of novel virulent strains into established herds. Early antimicrobial intervention dramatically improves survival rates and reduces the severity of long-term complications, making rapid recognition of clinical signs and prompt treatment initiation essential components of effective disease control programs.

Glasser's disease is caused by infection with Glaesserella parasuis, a small, gram-negative, pleomorphic bacterium that requires nicotinamide adenine dinucleotide for in vitro growth and demonstrates fastidious culture requirements that can complicate diagnostic isolation. The organism was recently reclassified from Haemophilus parasuis to Glaesserella parasuis based on genetic analysis demonstrating that it belongs in a separate genus from true Haemophilus species, though many practitioners and older literature continue using the former nomenclature. Fifteen serovars have been defined based on capsular polysaccharide antigens, with substantial variation in virulence between serovars and even between strains within the same serovar classification.

Virulent strains of Glaesserella parasuis possess multiple factors that enable invasion from the respiratory tract into systemic circulation and subsequent colonization of serous membranes throughout the body. Capsular polysaccharides provide protection against phagocytic killing by host immune cells, while outer membrane proteins facilitate adhesion to host tissues and evasion of complement-mediated bacteriolysis. Cytolethal distending toxin and other secreted factors damage host cells and contribute to the inflammatory response that produces the characteristic fibrinous exudates found coating affected serous surfaces.

Transmission of Glaesserella parasuis occurs primarily through direct nose-to-nose contact and inhalation of respiratory droplets, with colonized sows serving as the primary source of infection for nursing piglets who acquire the organism during the first days of life. In most herds, this early colonization occurs while maternal antibodies are still present, allowing piglets to develop active immunity before antibody levels decline without experiencing clinical disease. Problems arise when piglets either fail to receive adequate colostral antibodies or encounter particularly virulent strains against which maternal immunity provides insufficient protection.

Environmental and management factors play crucial roles in determining whether colonized pigs develop clinical Glasser's disease or remain healthy carriers of the organism. Weaning represents the single most significant risk factor, as the combined stresses of maternal separation, dietary changes, environmental transitions, and social reorganization compromise immune function precisely when maternal antibody protection is waning. Transportation stress, temperature extremes, poor ventilation, overcrowding, and mixing of pigs from multiple sources all increase disease risk by impairing host defenses and potentially introducing novel bacterial strains into immunologically naive populations.

Co-infections with other respiratory pathogens frequently predispose pigs to Glasser's disease by damaging respiratory epithelium and compromising local immune defenses that normally prevent Glaesserella parasuis from invading beyond the upper respiratory tract. Porcine reproductive and respiratory syndrome virus, swine influenza virus, porcine circovirus type 2, and Mycoplasma hyopneumoniae all enhance susceptibility to secondary Glaesserella parasuis infection through various immunosuppressive and epithelium-damaging mechanisms. Managing these primary pathogens through vaccination and biosecurity often produces substantial reductions in Glasser's disease incidence as an indirect benefit of controlling the underlying predisposing conditions.

Clinical signs of Glasser's disease typically appear suddenly in young pigs, most commonly during the first two weeks following weaning, though the incubation period varies from less than twenty-four hours to over a week depending on infectious dose, strain virulence, and host susceptibility factors. Affected pigs often develop high fever exceeding 106 degrees Fahrenheit, profound depression, complete anorexia, and reluctance to move, with some individuals found dead without premonitory signs when the disease progresses rapidly. The sudden onset and severity of illness in previously healthy-appearing pigs makes Glasser's disease one of the more alarming conditions nursery managers encounter, particularly during initial outbreaks in naive herds.

Polyserositis, the hallmark pathological lesion of Glasser's disease, produces clinical manifestations that vary depending on which serous membranes are most severely affected in individual animals. Pericarditis causes muffled heart sounds, jugular vein distension, and progressive cardiac dysfunction that may lead to sudden death or chronic wasting depending on severity. Pleuritis results in labored breathing, reluctance to lie on the affected side, and reduced exercise tolerance, while peritonitis produces abdominal pain evidenced by hunched posture, reluctance to move, and splinting of abdominal muscles when handled.

Arthritis represents one of the most visible and diagnostically useful manifestations of Glasser's disease, with affected joints becoming swollen, warm, and painful to palpation. Multiple joints are typically involved, with the carpus, tarsus, stifle, and elbow most commonly affected, though any synovial structure including tendon sheaths and bursae may develop infection. Affected pigs demonstrate severe lameness, often preferring to remain recumbent and moving only with great reluctance when forced to rise, sometimes adopting a dog-sitting posture to minimize weight-bearing on painful limbs. Joint swelling may become visually obvious within days of disease onset, with periarticular edema and fluctuant effusion palpable in severely affected joints.

Meningitis occurs in a significant proportion of Glasser's disease cases and produces distinctive neurological signs that help differentiate this condition from other causes of systemic illness in nursery pigs. Early neurological signs include depression, disorientation, and apparent blindness as inflammation affects the brain and cranial nerves. As meningitis progresses, affected pigs may develop head pressing, circling, star-gazing postures with dorsiflexion of the neck, muscle tremors, paddling movements, and convulsions. Terminal stages often involve lateral recumbency with opisthotonus and nystagmus before death occurs from respiratory failure or cardiovascular collapse.

Respiratory signs accompany the systemic manifestations in many cases, though primary pneumonia is less common than the polyserositis syndrome. Affected pigs may show increased respiratory rate and effort, nasal discharge, and coughing, particularly when pleuritis causes pain with thoracic wall movement. Careful auscultation may reveal pleural friction rubs in early disease stages before significant effusion accumulates, followed by decreased breath sounds ventrally as fibrinous fluid fills the pleural space.

The clinical course of Glasser's disease varies from peracute death within twenty-four hours to chronic wasting over several weeks, with the pattern depending on strain virulence, host factors, and treatment interventions. Peracute cases may present as sudden death with no observed clinical signs, discovered only during routine morning checks when affected pigs are found dead in apparently normal body condition. Acute cases progress over two to five days with obvious systemic illness, while chronic cases develop insidiously with progressive weight loss, poor growth, intermittent lameness, and rough hair coats in pigs that survive the initial acute phase but fail to fully recover.

Diagnosis of Glasser's disease requires integration of clinical findings, pathological observations, and laboratory confirmation because the clinical presentation, while often suggestive, overlaps substantially with other conditions affecting nursery-age pigs. Clinical suspicion arises when young pigs, particularly those recently weaned or subjected to other stressors, develop sudden high fever, depression, polyarthritis, and neurological signs, especially when multiple animals are affected within a short time period. Physical examination findings of swollen, painful joints combined with signs of respiratory distress and central nervous system involvement strongly suggest Glasser's disease but cannot definitively distinguish it from other causes of bacterial polyserositis.

Necropsy examination provides valuable diagnostic information and should be performed on freshly dead or euthanized animals whenever Glasser's disease is suspected. The characteristic gross lesions include fibrinous to fibrinopurulent exudate covering serous surfaces of the pericardium, pleura, peritoneum, joints, and meninges, with the amount and distribution of exudate varying between individuals. Affected pericardial sacs contain increased volumes of turbid, yellow fluid with fibrin strands and may show fibrous adhesions between pericardial and epicardial surfaces in chronic cases. Joint cavities contain increased volumes of cloudy synovial fluid with fibrin clots, and meninges appear thickened, congested, and covered with fibrinous exudate particularly over the cerebral convexities.

Bacterial culture remains the gold standard for confirming Glaesserella parasuis infection, though the organism's fastidious growth requirements necessitate careful sample collection and appropriate culture conditions for successful isolation. Samples for culture should include swabs or tissue from affected serous surfaces, joint fluid, cerebrospinal fluid if meningitis is present, and lung tissue if pneumonia is observed, collected aseptically from freshly dead animals before autolysis or environmental contamination obscure results. The laboratory must be notified that Glaesserella parasuis is suspected so appropriate NAD-supplemented media and culture conditions can be employed, as the organism will not grow on standard blood agar plates used for routine bacterial isolation.

Polymerase chain reaction testing provides rapid and sensitive detection of Glaesserella parasuis genetic material in clinical samples and has become increasingly available through veterinary diagnostic laboratories. PCR offers advantages over culture including faster turnaround time, ability to detect the organism even when antimicrobial treatment has been initiated, and capacity to identify bacteria in samples that are suboptimal for culture due to delays in submission or improper handling. Serotyping of isolates helps characterize the epidemiology of infection within herds and guides vaccine selection, as commercially available vaccines may not provide protection against all circulating serovars.

Treatment of Glasser's disease requires immediate initiation of appropriate antimicrobial therapy at the first recognition of clinical signs, as delays in treatment dramatically reduce survival rates and increase the likelihood of permanent complications in animals that do survive. Glaesserella parasuis demonstrates in vitro susceptibility to numerous antimicrobial classes including penicillins, cephalosporins, fluoroquinolones, potentiated sulfonamides, and tetracyclines, though resistance patterns vary geographically and between strains, making culture and sensitivity testing valuable for guiding treatment selection in herds with recurring problems. Initial treatment typically involves injectable antimicrobials chosen based on previous experience, pending culture results, with treatment extended for a minimum of five to seven days to ensure adequate bacterial killing and prevent relapse.

Penicillins and cephalosporins represent common first-line treatment choices due to generally good activity against Glaesserella parasuis combined with excellent tissue penetration including the central nervous system. Ampicillin, amoxicillin, and ceftiofur all demonstrate efficacy when administered early in the disease course at appropriate dosages, though treatment failures occur with increasing frequency as antimicrobial resistance emerges in bacterial populations exposed to selection pressure from routine antimicrobial use. Fluoroquinolones penetrate well into joints and cerebrospinal fluid, making them valuable for treating cases with prominent arthritis or meningitis, though regulatory restrictions limit their use in food-producing animals in many jurisdictions.

Anti-inflammatory therapy provides important supportive benefits by reducing fever, alleviating pain, and modulating the excessive inflammatory response responsible for much of the tissue damage observed in Glasser's disease. Non-steroidal anti-inflammatory drugs including meloxicam, flunixin meglumine, and ketoprofen help reduce fever and improve appetite while providing analgesia for animals suffering from painful polyarthritis. Corticosteroids are occasionally employed in severe cases, particularly those with prominent meningitis, though their immunosuppressive effects create concerns about prolonged bacterial survival and must be balanced against anti-inflammatory benefits.

Supportive care measures help optimize recovery by maintaining hydration, nutrition, and comfort in animals debilitated by acute illness. Electrolyte solutions administered orally or parenterally help correct dehydration and maintain electrolyte balance in animals unable or unwilling to drink adequately. Providing soft, palatable feeds encourages intake in animals with reduced appetite, while comfortable bedding and appropriate environmental temperature reduce stress on animals already compromised by infection. Separation of affected individuals from healthy pen mates reduces competition for resources and allows closer monitoring of treatment response.

Metaphylactic treatment of pen mates and other at-risk groups often proves necessary during outbreaks because clinical cases represent only a portion of animals likely to be infected during active disease transmission. Water medication with appropriate antimicrobials provides cost-effective treatment coverage for large numbers of animals, though palatability issues and variable water intake may limit effectiveness in some situations. In-feed medication offers an alternative for mass treatment but requires several days to achieve therapeutic tissue concentrations, making it more suitable for prevention than acute treatment. Individual injectable treatment of high-value animals or those in groups too small to justify mass medication ensures adequate dosing but increases labor costs substantially.

Treatment decisions in Glasser's disease must consider withdrawal times for antimicrobials administered to food-producing animals, ensuring that treated pigs do not enter the food supply until appropriate clearance periods have elapsed. Producers should maintain accurate treatment records documenting products used, dosages administered, and animals treated, allowing verification that withdrawal times have been satisfied before animals are sold for slaughter. Economic considerations also influence treatment intensity, with decisions about individual versus mass treatment, duration of therapy, and culling of severely affected animals all balancing animal welfare concerns against financial realities of commercial swine production.

Recovery from Glasser's disease depends heavily on the rapidity and appropriateness of treatment intervention, with pigs receiving effective antimicrobial therapy within the first twenty-four to forty-eight hours of illness demonstrating substantially better outcomes than those where treatment is delayed or inadequate. Fever typically resolves within twenty-four to forty-eight hours of initiating appropriate antimicrobial therapy, followed by gradual improvement in appetite and activity levels over the subsequent several days. However, resolution of joint swelling and return to normal mobility often requires one to two weeks or longer, and some animals develop chronic arthritis with permanent joint damage despite receiving prompt and appropriate treatment.

Post-treatment monitoring should assess response to therapy and identify animals that may require extended treatment, alternative antimicrobials, or supportive interventions to optimize recovery. Continued fever beyond forty-eight hours of treatment suggests either inappropriate antimicrobial selection, inadequate dosing, or complications such as abscess formation that may require modified approaches. Persistent lameness despite apparent resolution of systemic illness warrants examination for joint damage that may benefit from anti-inflammatory therapy extension or, in severe cases, may indicate animals unlikely to achieve satisfactory recovery.

Prognosis for individual animals varies considerably based on disease severity at treatment initiation, extent of tissue damage prior to bacterial control, and presence of complications that may impair long-term function. Pigs with uncomplicated acute disease that receive early appropriate treatment typically recover fully and eventually reach normal market weights, though growth rate depression during illness and recovery may delay marketing by days to weeks. Animals that develop severe polyarthritis, particularly with fibrous ankylosis of major joints, often remain chronically lame and fail to achieve competitive growth rates, making them poor candidates for continued feeding in commercial settings.

Return to production considerations for recovered animals include assessment of growth potential, feed conversion efficiency, and market timeline for finishing pigs, along with breeding potential for replacement gilts that may have experienced illness during the growing period. Chronic poor-doers that fail to regain normal growth trajectories despite extended recovery time typically warrant culling from the grow-finish population to prevent ongoing resource consumption without proportionate returns. Breeding animals that recover from Glasser's disease usually experience no long-term effects on reproductive function, though severe cases with residual joint damage may be unsuitable for breeding due to mobility limitations that impair mating or farrowing activities.

Prevention of Glasser's disease requires a multifaceted approach addressing bacterial exposure patterns, host immunity development, and management factors that influence disease expression in susceptible pig populations. Commercial vaccines containing killed Glaesserella parasuis cells of various serovars are available and provide useful protection when the vaccine serovars match those circulating in the target population, though the existence of numerous serovars with limited cross-protection creates challenges for vaccine effectiveness across all farm situations. Autogenous vaccines prepared from strains isolated from clinically affected pigs on specific farms offer tailored protection against the particular serovars causing problems in that population, though production time and cost considerations limit their applicability for acute outbreak situations.

Vaccination programs typically target sows during late gestation to enhance colostral antibody transfer to piglets, providing passive protection during the early post-weaning period when Glasser's disease risk peaks. Piglet vaccination may supplement sow programs in high-risk situations, with primary vaccination occurring during the nursing period and booster doses administered around weaning to stimulate active immunity before maternal antibody protection fully wanes. The timing and number of vaccine doses should be determined based on the specific farm situation, circulating strains, and disease patterns observed in unvaccinated populations.

Management practices that reduce stress during the weaning transition help minimize Glasser's disease incidence by supporting immune function during the critical period when maternal protection is declining. All-in-all-out pig flow prevents mixing of animals from multiple sources, reducing exposure to novel bacterial strains against which existing immunity may be inadequate. Maintaining appropriate stocking densities, providing adequate ventilation, and avoiding temperature extremes all support immune function and reduce disease pressure during the vulnerable post-weaning period.

Biosecurity measures that prevent introduction of novel Glaesserella parasuis strains into established herds help maintain stable endemic situations where most pigs develop immunity without clinical disease. Closed herd policies that minimize introduction of outside breeding stock, combined with quarantine and acclimation protocols for necessary additions, reduce the risk of introducing virulent strains against which resident animal immunity provides inadequate protection. Attention to vehicle and equipment sanitation prevents mechanical transmission of bacteria between farms, while visitor policies that minimize unnecessary animal area access reduce human-mediated introduction risks.

Monitoring and early intervention protocols enable rapid response to emerging Glasser's disease problems before they escalate into major outbreaks affecting substantial proportions of susceptible pig populations. Daily observation of nursery pigs for early signs of systemic illness, combined with prompt veterinary consultation and treatment initiation when problems are identified, helps limit disease spread and improve outcomes in affected individuals. Necropsy examination of mortality cases and diagnostic testing to confirm suspected Glasser's disease provides information needed to guide treatment selection and evaluate the need for vaccine program adjustments.

Daily management of nursery facilities where Glasser's disease has been identified or represents an ongoing risk requires consistent attention to environmental conditions, animal monitoring, and treatment protocols that collectively minimize disease impact while supporting optimal pig health and performance. Temperature control proves particularly important, as the stress of chilling or overheating compromises immune function and increases susceptibility to opportunistic bacterial infections including Glaesserella parasuis invasion. Nursery rooms should maintain temperatures appropriate for pig age and body weight, with supplemental heat sources available for younger pigs and adequate ventilation to prevent overheating as pigs grow and their thermoregulatory capabilities mature.

Ventilation management balances the need for fresh air exchange that dilutes airborne pathogen concentrations against the imperative to maintain appropriate temperatures and avoid drafts that stress young pigs. Minimum ventilation rates ensure adequate air quality even during cold weather when the temptation to restrict air exchange for temperature conservation may lead to excessive dust, ammonia, and pathogen accumulation. Air inlet and outlet placement should prevent drafts at pig level while ensuring uniform air distribution throughout the room, avoiding dead spots where stale air accumulates and disease-causing organisms concentrate.

Herd health programs in Glasser's disease-affected operations should establish clear protocols for case identification, treatment initiation, and communication between barn staff and veterinary advisors. Training programs ensure all personnel recognize early clinical signs and understand the urgency of treatment initiation, empowering stockpeople to begin therapy without waiting for veterinary confirmation of every individual case. Written treatment protocols specify product selection, dosing, duration, and withdrawal time documentation requirements, ensuring consistent appropriate therapy regardless of which staff member identifies and treats affected pigs.

Record keeping supports effective Glasser's disease management by tracking incidence patterns, treatment outcomes, and associations between disease occurrence and management factors that might be modified to reduce future risk. Mortality records should note suspected cause of death, age at death, and any recent stressors such as weaning, movement, or mixing events that might have contributed to disease development. Treatment records document antimicrobial use, enable withdrawal time compliance verification, and provide data for evaluating treatment effectiveness that guides protocol refinement over time.

Economic considerations for operations managing Glasser's disease include direct costs of mortality, treatment, and reduced growth performance, along with indirect costs of management time devoted to disease control and potential market penalties for animals with visible lesions or poor condition at slaughter. Cost-benefit analysis of prevention investments including vaccination programs, facility modifications, and management practice changes helps guide resource allocation toward interventions likely to provide positive returns through reduced disease losses. Benchmarking performance against industry standards and historical farm records helps identify whether disease management efforts are achieving expected results or require modification.

All commercial swine breeds demonstrate susceptibility to Glasser's disease when immunologically naive animals encounter virulent Glaesserella parasuis strains, with no evidence that genetic selection has produced breeds with enhanced resistance or susceptibility to this bacterial infection. Yorkshire, Landrace, Duroc, Hampshire, Pietrain, and other common commercial breeds all experience similar disease patterns when exposed under comparable conditions, making breed selection an ineffective strategy for Glasser's disease prevention. Similarly, crossbred pigs combining genetics from multiple foundation breeds show no meaningful differences in susceptibility compared to purebred animals from their parent populations.

Production system characteristics influence Glasser's disease risk more substantially than breed genetics, with high-health and specific-pathogen-free herds often experiencing more severe outbreaks than conventional operations due to lack of background immunity in pig populations that have never encountered the pathogen. Interestingly, the intensive selection for production traits including rapid growth, efficient feed conversion, and large litter size that characterizes modern commercial genetics has not demonstrably altered susceptibility to Glasser's disease, though some researchers have speculated that immune function may be indirectly affected by intense selection pressure on growth and reproduction.

Genetic approaches to Glasser's disease control remain largely unexplored in commercial swine breeding programs, though research has identified some variation in immune response parameters that might theoretically influence disease resistance if incorporated into selection indexes. Major histocompatibility complex haplotypes affect antigen presentation and T-cell responses to bacterial pathogens, and variation at these loci might influence individual pig responses to Glaesserella parasuis infection. However, the complexity of genetic influences on disease resistance combined with the difficulty of phenotyping resistance traits under commercial conditions has limited practical application of genomic selection for Glasser's disease resistance to date.

Several other bacterial infections produce polyserositis syndromes in young pigs that must be differentiated from Glasser's disease through appropriate diagnostic testing. Streptococcus suis infection causes meningitis, arthritis, and septicemia with clinical presentations overlapping substantially with Glasser's disease, and the two conditions frequently occur together as co-infections in nursery populations experiencing disease outbreaks. Mycoplasma hyorhinis causes polyserositis and arthritis in young pigs with gross lesions nearly identical to those of Glasser's disease, requiring culture or molecular diagnostics for differentiation since treatment approaches differ somewhat between bacterial causes.

Conditions that predispose pigs to secondary Glaesserella parasuis infection include viral diseases that compromise respiratory epithelium and immune function. Porcine reproductive and respiratory syndrome virus infection frequently precedes Glasser's disease outbreaks by damaging pulmonary macrophages and creating conditions favorable for bacterial invasion of normally protected body compartments. Porcine circovirus type 2 causes immunosuppression that enhances susceptibility to multiple opportunistic bacterial infections including Glaesserella parasuis. Effective control of these primary viral pathogens often produces substantial reductions in Glasser's disease incidence as an indirect benefit.

Complications and sequelae of Glasser's disease include chronic arthritis with fibrous ankylosis that permanently impairs mobility in recovered animals, pericardial adhesions that may restrict cardiac function and contribute to poor growth performance, and pleural adhesions discovered at slaughter that may result in carcass condemnation or trim loss. Animals that survive acute meningitis occasionally develop residual neurological deficits including behavioral abnormalities, coordination problems, or seizure activity, though these chronic neurological sequelae are relatively uncommon given that most pigs with severe meningitis die during the acute phase rather than surviving to experience long-term complications.